Description
Description | Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer. |
Synonyms | IMMU130, Labetuzumab-SN38, hMN14-SN38, IMMU 130, IMMU-130 |
Molecular Weight |
1587.76 |
Formula | C75H102N12O24S |
CAS No. | 1469876-18-3 |
Storage
store at -20 ℃
Solubility Information
( < 1 mg/ml refers to the product slightly soluble or insoluble )